| Dr Chandler H Park, MD, MSC | |
|
1263 Hospital Dr Nw Ste 110, Corydon, IN 47112-2173 | |
| (812) 734-0912 | |
| (502) 629-2055 |
| Full Name | Dr Chandler H Park |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 17 Years |
| Location | 1263 Hospital Dr Nw Ste 110, Corydon, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417137365 | NPI | - | NPPES |
| 201083260 | Medicaid | IN | |
| 57.013780 | Other | OH | CREDENTIAL NUMBER |
| P01150420 | Other | IN | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 48923 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Norton Hospitals, Inc | Louisville, KY | Hospital |
| Harrison County Hospital | Corydon, IN | Hospital |
| Clark Memorial Hospital | Jeffersonville, IN | Hospital |
| Hardin Memorial Hospital | Elizabethtown, KY | Hospital |
| Baptist Health Floyd | New albany, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Norton Hospitals Inc | 9830001528 | 104 |
| Kentucky Orthopedic Rehabilitation Llc | 0345157293 | 683 |
| Norton Hospitals Inc | 9830001528 | 104 |
News Archive
CANCER RESEARCH UK and Cancer Research Technology , the charity's development and commercialisation arm, have reached an agreement with Asterias Biotherapeutics, Inc., a biotechnology company in the emerging field of regenerative medicine, to take forward Asterias' novel immunotherapy treatment AST-VAC2 into clinical trials in subjects with non-small cell lung cancer.
Frisbie Memorial Hospital is now using low-dose CT scanning as a follow-up tool for screening colorectal cancer. This procedure, known as virtual colonoscopy, does not replace the effective and most reliable colorectal cancer screening tool, which is the colonoscopy, but rather it is utilized as a means to obtain additional images of the colon and rectum.
Columbia University Medical Center and University of Iowa scientists have used a new gene-editing technology called CRISPR, to repair a genetic mutation responsible for retinitis pigmentosa (RP), an inherited condition that causes the retina to degrade and leads to blindness in at least 1.5 million cases worldwide.
Ligand Pharmaceuticals Incorporated announced today that it has completed the acquisition of Neurogen Corporation, following approval of the transaction by Neurogen stockholders earlier today. As a result, Ligand gains a fully funded partnership with Merck & Co., additional pipeline assets, drug discovery resources and additional cash balances.
› Verified 7 days ago
| Entity Name | Norton Hospitals Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073568879 PECOS PAC ID: 9830001528 Enrollment ID: O20040803000379 |
News Archive
CANCER RESEARCH UK and Cancer Research Technology , the charity's development and commercialisation arm, have reached an agreement with Asterias Biotherapeutics, Inc., a biotechnology company in the emerging field of regenerative medicine, to take forward Asterias' novel immunotherapy treatment AST-VAC2 into clinical trials in subjects with non-small cell lung cancer.
Frisbie Memorial Hospital is now using low-dose CT scanning as a follow-up tool for screening colorectal cancer. This procedure, known as virtual colonoscopy, does not replace the effective and most reliable colorectal cancer screening tool, which is the colonoscopy, but rather it is utilized as a means to obtain additional images of the colon and rectum.
Columbia University Medical Center and University of Iowa scientists have used a new gene-editing technology called CRISPR, to repair a genetic mutation responsible for retinitis pigmentosa (RP), an inherited condition that causes the retina to degrade and leads to blindness in at least 1.5 million cases worldwide.
Ligand Pharmaceuticals Incorporated announced today that it has completed the acquisition of Neurogen Corporation, following approval of the transaction by Neurogen stockholders earlier today. As a result, Ligand gains a fully funded partnership with Merck & Co., additional pipeline assets, drug discovery resources and additional cash balances.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Chandler H Park, MD, MSC Po Box 2119, Elizabethtown, KY 42702-2119 Ph: (270) 737-1212 | Dr Chandler H Park, MD, MSC 1263 Hospital Dr Nw Ste 110, Corydon, IN 47112-2173 Ph: (812) 734-0912 |
News Archive
CANCER RESEARCH UK and Cancer Research Technology , the charity's development and commercialisation arm, have reached an agreement with Asterias Biotherapeutics, Inc., a biotechnology company in the emerging field of regenerative medicine, to take forward Asterias' novel immunotherapy treatment AST-VAC2 into clinical trials in subjects with non-small cell lung cancer.
Frisbie Memorial Hospital is now using low-dose CT scanning as a follow-up tool for screening colorectal cancer. This procedure, known as virtual colonoscopy, does not replace the effective and most reliable colorectal cancer screening tool, which is the colonoscopy, but rather it is utilized as a means to obtain additional images of the colon and rectum.
Columbia University Medical Center and University of Iowa scientists have used a new gene-editing technology called CRISPR, to repair a genetic mutation responsible for retinitis pigmentosa (RP), an inherited condition that causes the retina to degrade and leads to blindness in at least 1.5 million cases worldwide.
Ligand Pharmaceuticals Incorporated announced today that it has completed the acquisition of Neurogen Corporation, following approval of the transaction by Neurogen stockholders earlier today. As a result, Ligand gains a fully funded partnership with Merck & Co., additional pipeline assets, drug discovery resources and additional cash balances.
› Verified 7 days ago
Devi Kathleen Pierce, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1263 Hospital Dr Nw Ste 280, Corydon, IN 47112 Phone: 812-738-4251 | |
Dr. Beaujon Davidson, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1141 Hospital Dr Nw, Corydon, IN 47112 Phone: 812-738-4251 | |
Michael G Bonacum, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1263 Hospital Dr Nw, Suite 250, Corydon, IN 47112 Phone: 812-738-8136 Fax: 812-738-3155 | |
Dr. John Brent Murphy, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1141 Hospital Dr Nw, Corydon, IN 47112 Phone: 812-738-4251 | |
Dr. Stefanie Ann Colavito, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1141 Hospital Dr Nw, Corydon, IN 47112 Phone: 812-738-4251 | |
Olivia Paige Beam, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2230 Edsel Ln Nw Ste 1, Corydon, IN 47112 Phone: 812-734-0303 Fax: 812-225-5145 |